ATE210672T1 - Verabreichung von valienaminverwandten disaccharidverindungen zur verminderung von entzündungen bei säugern, die durch kontakt mit einem antigen sensibilisiert sind - Google Patents

Verabreichung von valienaminverwandten disaccharidverindungen zur verminderung von entzündungen bei säugern, die durch kontakt mit einem antigen sensibilisiert sind

Info

Publication number
ATE210672T1
ATE210672T1 AT96917312T AT96917312T ATE210672T1 AT E210672 T1 ATE210672 T1 AT E210672T1 AT 96917312 T AT96917312 T AT 96917312T AT 96917312 T AT96917312 T AT 96917312T AT E210672 T1 ATE210672 T1 AT E210672T1
Authority
AT
Austria
Prior art keywords
administration
antigen
valiemine
contact
reduce inflammation
Prior art date
Application number
AT96917312T
Other languages
English (en)
Inventor
Om P Srivastava
Roman Szweda
Richard H Smith
Robert M Ippolito
Ulrike Spohr
Original Assignee
Alberta Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alberta Res Council filed Critical Alberta Res Council
Application granted granted Critical
Publication of ATE210672T1 publication Critical patent/ATE210672T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96917312T 1995-06-06 1996-06-06 Verabreichung von valienaminverwandten disaccharidverindungen zur verminderung von entzündungen bei säugern, die durch kontakt mit einem antigen sensibilisiert sind ATE210672T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/466,621 US5571796A (en) 1995-06-06 1995-06-06 Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen
PCT/CA1996/000388 WO1996039412A1 (en) 1995-06-06 1996-06-06 Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen

Publications (1)

Publication Number Publication Date
ATE210672T1 true ATE210672T1 (de) 2001-12-15

Family

ID=23852477

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96917312T ATE210672T1 (de) 1995-06-06 1996-06-06 Verabreichung von valienaminverwandten disaccharidverindungen zur verminderung von entzündungen bei säugern, die durch kontakt mit einem antigen sensibilisiert sind

Country Status (7)

Country Link
US (2) US5571796A (de)
EP (1) EP0833833B1 (de)
AT (1) ATE210672T1 (de)
AU (1) AU5994596A (de)
CA (1) CA2257100A1 (de)
DE (1) DE69617951T2 (de)
WO (1) WO1996039412A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571796A (en) * 1995-06-06 1996-11-05 Alberta Research Council Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen
US6828119B2 (en) * 2001-01-04 2004-12-07 Bristol Myers Squibb Company Enzymatic deprotection of amines and hydroxides
JP4602249B2 (ja) 2003-05-19 2010-12-22 生化学工業株式会社 カルバ糖アミン誘導体の酸付加塩
US8101732B2 (en) * 2008-09-17 2012-01-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Methods of producing validamycin A analogs and uses thereof
CA2939491A1 (en) * 2014-02-14 2015-08-20 Toa Eiyo Ltd. Cyclic hydrocarbon compound
JP2023511756A (ja) 2020-01-31 2023-03-22 アヴィラー セラピューティクス インコーポレイテッド 細胞外タンパク質を分解するａｓｇｐｒ結合性化合物
JP2024517812A (ja) 2021-05-03 2024-04-23 アヴィラー セラピューティクス インコーポレイテッド 免疫グロブリン及びその他のタンパク質を分解する強力なａｓｇｐｒ結合性化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5754593A (en) * 1980-09-16 1982-04-01 Takeda Chem Ind Ltd Preparation of valienamine
JPS5764648A (en) * 1980-10-06 1982-04-19 Takeda Chem Ind Ltd N-substituted derivative of valienamine, its preparation, and alpha-glucosidase inhibitor
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
WO1986005094A1 (fr) * 1985-03-08 1986-09-12 Takeda Chemical Industries, Ltd. Agent antiobesite et composition
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
JPH05247078A (ja) * 1992-03-03 1993-09-24 Japan Tobacco Inc 糖化合物、シアル酸含有糖鎖類生合成阻害剤、その製造方法、並びに新規な中間体
GB2265475A (en) * 1992-03-18 1993-09-29 Yang Tai Her Dc motor-generator dynamic feedback control circuit
US5571796A (en) * 1995-06-06 1996-11-05 Alberta Research Council Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen

Also Published As

Publication number Publication date
US5814616A (en) 1998-09-29
AU5994596A (en) 1996-12-24
CA2257100A1 (en) 1996-12-12
WO1996039412A1 (en) 1996-12-12
DE69617951T2 (de) 2002-08-01
EP0833833B1 (de) 2001-12-12
EP0833833A1 (de) 1998-04-08
US5571796A (en) 1996-11-05
DE69617951D1 (de) 2002-01-24

Similar Documents

Publication Publication Date Title
DE69332518D1 (de) Unterdrückung von autoimmunkrankheiten durch antigene in wartestellung
DK0817847T4 (da) IL-17-receptor
DK0814831T3 (da) Medikamenter til behandling af autoimmune sygdomme under anvendelse af interferon-tau
IT8124160A0 (it) Procedimento per la polimerizzazione di diolefine coniugate e mezzi adatti allo scopo.
FI870104A7 (fi) Negatiivisia, valosähköisen vastuksen omaavia koostumuksia ja menetelmiä lämmönkestävien negatiivikuvien valmistamiseksi käyttämällä niitä.
JPS52134692A (en) Photopolymerizable composition
DK0914114T3 (da) Fremgangsmåder til behandling af type I-hypersensitivitet under anvendelse af monophosphoryl-lipid A
EA199700265A1 (ru) Добавочный протеин рецептора интерлейкина-1 человека
BR9912702A (pt) Composto e método para a prevenção e/ou para o tratamento de alergias
ATE210672T1 (de) Verabreichung von valienaminverwandten disaccharidverindungen zur verminderung von entzündungen bei säugern, die durch kontakt mit einem antigen sensibilisiert sind
ATE219681T1 (de) Behandlung von krebs durch verwendung von hsv- mutanten
MY107079A (en) Method of reducing immunoglobulin e responses
BE888906A (fr) Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal
AU4695479A (en) Purified antigen
EP0542860A4 (en) Immunosuppressive compositions
EP0282343A3 (de) Verfahren zur Stimulierung der Immunreponsibilität zu bestimmten Antigenen
JPS56126810A (en) Preparation for light waveguide line
Furze et al. Comparative dynamics and phenotype of the murine immune response to Trichinella spiralis and Trichinella pseudospiralis
IT8220747A0 (it) Procedimento per la polimerizzazione di diolefine coniugate e mezzi adatti allo scopo.
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
EP0570951A3 (de) Mechanische Verpackung eines weiterentwickelten parallelen Gatterprozessors.
JPS5230428A (en) Photoresist exposure method
DK0589348T4 (da) Fremgangsmåde til immunkemisk kvantificering af inaktiverede antigener
JPS5225487A (en) Incandescent lamp
Gemmell et al. Genetic variation in the recognition of Porphyromonas gingivalis antigens in mice